Vaccinex, Inc. Profile Avatar - Palmy Investing

Vaccinex, Inc.

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, n…

Biotechnology
US, Rochester [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Vaccinex, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of VCNX's Analysis
CIK: 1205922 CUSIP: 918640103 ISIN: US9186403013 LEI: - UEI: -
Secondary Listings
VCNX has no secondary listings inside our databases.